REPORT ID 3344

United States In Vitro Diagnostics (IVD) Quality Control Market Report 2017

Publish Date
13-Dec-17
Pages
111
Format
Electronic (PDF)

In this report, the United States In Vitro Diagnostics (IVD) Quality Control market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of In Vitro Diagnostics (IVD) Quality Control in these regions, from 2012 to 2022 (forecast).

United States In Vitro Diagnostics (IVD) Quality Control market competition by top manufacturers/players, with In Vitro Diagnostics (IVD) Quality Control sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Roche Diagnostics (Switzerland)
    Abbott Laboratories (US)
    Thermo Fisher Scientific (US)
    Helena Laboratories (US)
    Bio-Rad Laboratories (US)
    Danaher (US)
    Sero AS (Norway)
    Randox Laboratories (UK)
    Siemens AG (Germany)
    Technopath Clinical Diagnostics (Ireland)
    Ortho Clinical Diagnostics (US)
    Sun Diagnostics (US)
    Sysmex (Japan)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Serum/Plasma-based Products
    Whole Blood-based Products
    Urine-based Products
    Other Quality Control Products
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Clinics
    Research Institutes and Academic Institutes
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States In Vitro Diagnostics (IVD) Quality Control Market Report 2017
1 In Vitro Diagnostics (IVD) Quality Control Overview
    1.1 Product Overview and Scope of In Vitro Diagnostics (IVD) Quality Control
    1.2 Classification of In Vitro Diagnostics (IVD) Quality Control by Product Category
        1.2.1 United States In Vitro Diagnostics (IVD) Quality Control Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States In Vitro Diagnostics (IVD) Quality Control Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Serum/Plasma-based Products
        1.2.4 Whole Blood-based Products
        1.2.5 Urine-based Products
        1.2.6 Other Quality Control Products
    1.3 United States In Vitro Diagnostics (IVD) Quality Control Market by Application/End Users
        1.3.1 United States In Vitro Diagnostics (IVD) Quality Control Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Research Institutes and Academic Institutes
        1.3.5 Other
    1.4 United States In Vitro Diagnostics (IVD) Quality Control Market by Region
        1.4.1 United States In Vitro Diagnostics (IVD) Quality Control Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West In Vitro Diagnostics (IVD) Quality Control Status and Prospect (2012-2022)
        1.4.3 Southwest In Vitro Diagnostics (IVD) Quality Control Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic In Vitro Diagnostics (IVD) Quality Control Status and Prospect (2012-2022)
        1.4.5 New England In Vitro Diagnostics (IVD) Quality Control Status and Prospect (2012-2022)
        1.4.6 The South In Vitro Diagnostics (IVD) Quality Control Status and Prospect (2012-2022)
        1.4.7 The Midwest In Vitro Diagnostics (IVD) Quality Control Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of In Vitro Diagnostics (IVD) Quality Control (2012-2022)
        1.5.1 United States In Vitro Diagnostics (IVD) Quality Control Sales and Growth Rate (2012-2022)
        1.5.2 United States In Vitro Diagnostics (IVD) Quality Control Revenue and Growth Rate (2012-2022)

2 United States In Vitro Diagnostics (IVD) Quality Control Market Competition by Players/Suppliers
    2.1 United States In Vitro Diagnostics (IVD) Quality Control Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States In Vitro Diagnostics (IVD) Quality Control Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States In Vitro Diagnostics (IVD) Quality Control Average Price by Players/Suppliers (2012-2017)
    2.4 United States In Vitro Diagnostics (IVD) Quality Control Market Competitive Situation and Trends
        2.4.1 United States In Vitro Diagnostics (IVD) Quality Control Market Concentration Rate
        2.4.2 United States In Vitro Diagnostics (IVD) Quality Control Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers In Vitro Diagnostics (IVD) Quality Control Manufacturing Base Distribution, Sales Area, Product Type

3 United States In Vitro Diagnostics (IVD) Quality Control Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States In Vitro Diagnostics (IVD) Quality Control Sales and Market Share by Region (2012-2017)
    3.2 United States In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Region (2012-2017)
    3.3 United States In Vitro Diagnostics (IVD) Quality Control Price by Region (2012-2017)

4 United States In Vitro Diagnostics (IVD) Quality Control Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States In Vitro Diagnostics (IVD) Quality Control Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States In Vitro Diagnostics (IVD) Quality Control Revenue and Market Share by Type (2012-2017)
    4.3 United States In Vitro Diagnostics (IVD) Quality Control Price by Type (2012-2017)
    4.4 United States In Vitro Diagnostics (IVD) Quality Control Sales Growth Rate by Type (2012-2017)

5 United States In Vitro Diagnostics (IVD) Quality Control Sales (Volume) by Application (2012-2017)
    5.1 United States In Vitro Diagnostics (IVD) Quality Control Sales and Market Share by Application (2012-2017)
    5.2 United States In Vitro Diagnostics (IVD) Quality Control Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States In Vitro Diagnostics (IVD) Quality Control Players/Suppliers Profiles and Sales Data
    6.1 Roche Diagnostics (Switzerland)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 In Vitro Diagnostics (IVD) Quality Control Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Roche Diagnostics (Switzerland) In Vitro Diagnostics (IVD) Quality Control Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Abbott Laboratories (US)
        6.2.2 In Vitro Diagnostics (IVD) Quality Control Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Abbott Laboratories (US) In Vitro Diagnostics (IVD) Quality Control Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Thermo Fisher Scientific (US)
        6.3.2 In Vitro Diagnostics (IVD) Quality Control Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Thermo Fisher Scientific (US) In Vitro Diagnostics (IVD) Quality Control Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Helena Laboratories (US)
        6.4.2 In Vitro Diagnostics (IVD) Quality Control Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Helena Laboratories (US) In Vitro Diagnostics (IVD) Quality Control Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Bio-Rad Laboratories (US)
        6.5.2 In Vitro Diagnostics (IVD) Quality Control Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Bio-Rad Laboratories (US) In Vitro Diagnostics (IVD) Quality Control Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Danaher (US)
        6.6.2 In Vitro Diagnostics (IVD) Quality Control Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Danaher (US) In Vitro Diagnostics (IVD) Quality Control Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Sero AS (Norway)
        6.7.2 In Vitro Diagnostics (IVD) Quality Control Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Sero AS (Norway) In Vitro Diagnostics (IVD) Quality Control Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Randox Laboratories (UK)
        6.8.2 In Vitro Diagnostics (IVD) Quality Control Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Randox Laboratories (UK) In Vitro Diagnostics (IVD) Quality Control Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Siemens AG (Germany)
        6.9.2 In Vitro Diagnostics (IVD) Quality Control Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Siemens AG (Germany) In Vitro Diagnostics (IVD) Quality Control Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Technopath Clinical Diagnostics (Ireland)
        6.10.2 In Vitro Diagnostics (IVD) Quality Control Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Technopath Clinical Diagnostics (Ireland) In Vitro Diagnostics (IVD) Quality Control Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Ortho Clinical Diagnostics (US)
    6.12 Sun Diagnostics (US)
    6.13 Sysmex (Japan)

7 In Vitro Diagnostics (IVD) Quality Control Manufacturing Cost Analysis
    7.1 In Vitro Diagnostics (IVD) Quality Control Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of In Vitro Diagnostics (IVD) Quality Control

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 In Vitro Diagnostics (IVD) Quality Control Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of In Vitro Diagnostics (IVD) Quality Control Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States In Vitro Diagnostics (IVD) Quality Control Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States In Vitro Diagnostics (IVD) Quality Control Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States In Vitro Diagnostics (IVD) Quality Control Sales Volume Forecast by Type (2017-2022)
    11.3 United States In Vitro Diagnostics (IVD) Quality Control Sales Volume Forecast by Application (2017-2022)
    11.4 United States In Vitro Diagnostics (IVD) Quality Control Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer